These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Pharmacological characterization of VIP receptors in human lung membranes. Robberecht P; Waelbroeck M; de Neef P; Camus JC; Coy DH; Christophe J Peptides; 1988; 9(2):339-45. PubMed ID: 2836826 [TBL] [Abstract][Full Text] [Related]
28. Cerebral vascular adenylate cyclase: evidence for coupling to receptors for vasoactive intestinal peptide and parathyroid hormone. Huang M; Rorstad OP J Neurochem; 1984 Sep; 43(3):849-56. PubMed ID: 6086840 [TBL] [Abstract][Full Text] [Related]
29. Characterization of vasoactive intestinal peptide receptors in canine liver membranes. Kiso T; Ito S; Ohta T; Asano T; Nakazato Y Biochem Pharmacol; 1994 Jan; 47(2):241-5. PubMed ID: 8304967 [TBL] [Abstract][Full Text] [Related]
30. Secretin receptors on neuroblastoma cell membranes: characterization of 125I-labeled secretin binding and association with adenylate cyclase. Roth BL; Beinfeld MC; Howlett AC J Neurochem; 1984 Apr; 42(4):1145-52. PubMed ID: 6321661 [TBL] [Abstract][Full Text] [Related]
31. Vasoactive intestinal polypeptide-related peptides modulate tyrosine hydroxylase gene expression in PC12 cells through multiple adenylate cyclase-coupled receptors. Wessels-Reiker M; Basiboina R; Howlett AC; Strong R J Neurochem; 1993 Mar; 60(3):1018-29. PubMed ID: 8094740 [TBL] [Abstract][Full Text] [Related]
32. Receptors for vasoactive intestinal peptide and secretin on small intestinal epithelial cells. Binder HJ; Lemp GF; Gardner JD Am J Physiol; 1980 Mar; 238(3):G190-6. PubMed ID: 6245588 [TBL] [Abstract][Full Text] [Related]
33. Demonstration of a functional receptor for vasoactive intestinal polypeptide on Molt 4b T lymphoblasts. Beed EA; O'Dorisio MS; O'Dorisio TM; Gaginella TS Regul Pept; 1983 Apr; 6(1):1-12. PubMed ID: 6306732 [TBL] [Abstract][Full Text] [Related]
34. Impairment of hormone-stimulated cardiac adenylate cyclase activity in the genetically obese (fa/fa) Zucker rat. Chatelain P; Robberecht P; De Neef P; Camus JC; Poloczek P; Christophe J Pflugers Arch; 1981 Apr; 390(1):10-6. PubMed ID: 6264381 [TBL] [Abstract][Full Text] [Related]
35. Properties of vasoactive-intestinal-peptide receptors and beta-adrenoceptors in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3. Abello J; Damien C; De Neef P; Tastenoy M; Hooghe R; Robberecht P; Christophe J Eur J Biochem; 1989 Aug; 183(2):263-7. PubMed ID: 2547606 [TBL] [Abstract][Full Text] [Related]
36. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells. Gespach C; Bawab W; de Cremoux P; Calvo F Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044 [TBL] [Abstract][Full Text] [Related]
37. Stimulation of the adenylyl cyclase activity in human endometrial membranes by VIP and related peptides. Bajo AM; Guijarro LG; Juarranz MG; Valenzuela P; Martinez P; Prieto JC Biosci Rep; 1993 Apr; 13(2):69-77. PubMed ID: 8397008 [TBL] [Abstract][Full Text] [Related]
38. Guanyl nucleotide regulation of vasoactive intestinal peptide interaction with rat liver membranes. Ramírez-Cárdenas R; Prieto JC; Guerrero JM; Goberna R Rev Esp Fisiol; 1981 Mar; 37(1):9-16. PubMed ID: 6264553 [TBL] [Abstract][Full Text] [Related]
39. Interaction of Gila monster venom with secretin receptors in rat pancreatic membranes. Gillet L; Robberecht P; Waelbroeck M; Camus JC; De Neef P; König W; Christophe J Peptides; 1984; 5(2):407-9. PubMed ID: 6089139 [TBL] [Abstract][Full Text] [Related]
40. Vasoactive intestinal polypeptide: specific binding to rat brain membranes. Taylor DP; Pert CB Proc Natl Acad Sci U S A; 1979 Feb; 76(2):660-4. PubMed ID: 218214 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]